Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat

International Journal of Obesity

Volumn 24, Issue 8, 2000, Pages 945-953

  Lefevre, M ^a   Lovejoy, J C ^a   DeFelice, S M ^a   Keener, J W ^a   Bray, G A ^a   Ryan, D H ^a   Hwang, D H ^a   Greenway, F L ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

ApoA IV; Gene polymorphisms; Genetics; Obesity

Indexed keywords

APOLIPOPROTEIN A4;

ADULT; AGED; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMPEDANCE; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL;

EID: 0033866395     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801260     Document Type: Article

References (59)

1. 1 Karathanasis SK, Yunis I. Structure, evolution, and tissue-specific synthesis of human apolipoprotein A-IV. Biochemistiy 1986; 25: 3962-3970.
2. 2 Elshourbagy NA, Boguski MS, Liao WS, Jefferson LS, Gordon JI, Taylor JM. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc Natl Acad Sci USA 1985; 82: 8242-8246.
3. 3 Staels B, van Tol A, Verhoeven G, Auwerx J. Apolipoprotein A-IV messenger ribonucleic acid abundance is regulated in a tissue-specific manner. Endocrinology 1990; 126: 2153-2163.
4. 4 Uchida T, Masumoto A, Sakamoto S, Koga S, Nawata H. Effect of insulin, glucagon or dexamethasone on the production of apolipoprotein A-IV in cultured rat hepatocytes. Atherosclerosis 1991; 87: 195-202.
5. 5 Green PHR, Glickman RM, Riley JW, Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 1980; 65: 911-919.
6. 6 Apfelbaum TF, Davidson NO, Glickman RM. Apolipoprotein A-IV synthesis in the rat intestine: regulation by dietary triglyceride. Am J Physiol 1987; 252: G662-G666.
7. 7 Black DD, Wang H, Hunter F, Zhan R. Intestinal expression of apolipoprotein A-IV and C-III is coordinately regulated by dietary lipid in newborn swine. Biochem Biophys Res Commun 1996; 221: 619-624.
8. 8 Kaolgeris TJ, Fukagawa K, Tso P. Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J Lipid Res; 1994: 35: 1141-1151.
9. 9 Ohta T, Fidge N, Nestel PJ. Studies on the in vivo and in vitro distribution of apoliprotein A-IV in human plasma and lymph. J Clin Invest 1985; 76: 1252-1260.
10. 10 Bisgaier CL, Sachdev OP, Megna L, Glickman RM. Distribution of apoliprotein A-IV in human plasma. J Lipid Res 1985; 26: 11-25.
11. 11 Lagrost L, Gambert P, Boquillon M, Lallemant C. Evidence for high density lipoproteins as the major apoliprotein A-IV-containing fraction in normal human serum. J Lipid Res 1989; 30: 1525-1534.
12. 12 Bisgaier CL, Sachdev OP, Lee ES, Williams KJ, Blum CB, Glickman RM. Effect of lethicin : cholesterol acyltransferase on distribution of apoliprotein A-IV among lipoproteins of human plasma. J Lipid Res 1987; 28: 693-703.
13. 13 Bisgaier CL, Sienbenkas MV, Hesler CB, Swenson TL, Blum CB, Marcel YL, Milne RW, Glickman RM, Tall AR. Effects of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteins. J Lipid Res 1989; 30: 1025-1031.
14. 14 Lefevre M, Chuang MY, Roheim PS. ApoA-IV metabolism in the rate: role of lipoprotein lipase and apoliprotein transfer. J Lipid Res 1986; 27: 1163-1173.
15. 15 Rader DJ, Schafer J, Lohse P, Verges B, Kindt M, Zech LA, Steinmetz A, Brewer HB, Jr. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein. J Clin Invest 1993; 92: 1009-1017.
16. 16 Seishima M, Noma A, Torizawa H, Muto Y. Changes in serum apolipoprotein levels after oral administration of fat in human subjects. Atherosclerosis 1988; 73: 39-43.
17. 17 Weinberg RB, Dantzker C, Patton CS. Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology 1990; 98: 17-24.
18. 18 Steinmetz A, Utermann G. Activation of lecithin:cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 1985; 260: 2258-2264.
19. 19 Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL. Lipoprotein apoC-II activation by lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 1990; 265: 4266-4272.
20. 20 Guyard-Dangremont V, Lagrost L, Gambert P. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. J Lipid Res 1994; 35: 982-992.
21. 21 Stein O, Stein Y, Lefevre M, Roheim PS. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta 1986; 878: 7-13.
22. 22 Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart J-C, Ailhaud G. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 1990; 265: 7859-7863.
23. 23 Okumura T, Fukagawa K, Tso P, Taylor IL, Pappas TN. Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. Am J Physiol 1996; 33: G49-G53.
24. 24 Fujimoto K, Cardelli JA, Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol 1992; 262: G1002-G1006
25. 25 Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 1993; 91: 1830-1833.
26. 26 Fujimoto K, Machidori H, Iwakiri R, Yamamoto K, Fujisaki J, Sakata T, Tso P. Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity in rats. Brain Res 1993; 608: 233-237.
27. 27 Lohse P, Kindt MR, Rader DJ, Brewer HB, Jr. Three genetic variants of human plasma apolipoprotein A-IV. ApoA-IV-1(Thr347→Ser), apoA-IV-0(Lys167→Glu,Gln360→His), and apoA-IV-3(Glu165→Lys). J Biol Chem 1991; 266: 13513-13518.
28. 28 Lohse P, Kindt MR, Ráder DJ, Brewer HB, Jr. Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J Biol Chem 1990; 265: 10061-10064.
29. 29 Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann G. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 1988; 79: 368-372.
30. 30 Verges BL, Vaillant G, Goux A, Lagrost L, Brun JM, Gambert P. Apolipoprotein A-IV levels and phenotype distribution in NIDDM. Diabetes Care 1994; 17: 810-817.
31. 31 Hanis CL, Douglas TC, Hewett-Emmett D. Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum Genet 1991; 86: 323-325.
32. 32 von Eckardstein A, Funke H, Schulte M, Erren M, Schulte H, Assmann G. Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B-and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 1992; 50: 1115-1128.
33. 33 Kamboh MI, Hamman RF, Iyengar S, Aston CE, Ferrell RE. Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals. Atherosclerosis 1991; 91: 25-34.
34. 34 Eichner JE, Kuller LH, Ferrell RE, Kamboh MI. Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet Epidemiol 1989; 6: 493-499.
35. 35 von Eckardstein A, Heinrich J, Funke H, Schulte H, Schonfeld R, Kohler E, Steinmetz A, Assmann G. Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients. Arterioscler Thromb 1993; 13: 240-246.
36. 36 Menzel HJ, Sigurdsson G, Boerwinkle E, Schrangl-Will S, Dieplinger H, Utermann G. Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 1990; 84: 344-346.
37. 37 Saha N, Wang G, Vasisht S, Kamboh MI. Influence of two apo A4 polymorphisms at codon 347 and 360 on non-fasting plasma lipoprotein-lipids and apolipoproteins in Asian Indians. Atherosclerosis 1997; 131: 249-255.
38. 38 Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 1988; 47: 7-14.
39. 39 Hixson JE, Powers PK. Restriction isotyping of human apolipoprotein A-IV: rapid typing of known isoforms and detection of a new isoform that deletes a conserved repeat. J Lipid Res 1991; 32: 1529-1535.
40. 40 Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res 1997; 5: 542-548.
41. 41 Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272: 205-211.
42. 42 Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 1991; 11: 1330-1348.
43. 43 Elshourbagy NA, Walker DW, Boguski MS, Gordon JI, Taylor JM. The nucleotide and derived amino aid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III. J Biol Chem 1986; 261: 1998-2002.
44. 44 Weinberg RB, Jordan MK, Steinmetz A. Distinctive structure and function of human apolipoprotein variant apoA-IV2. J Biol Chem 1990; 265: 18372-18378.
45. 45 Fisher RM, Burke H, nicaud V, Enholm C, Humphries SE. Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J Lipid Res 1999; 40: 287-294.
46. 46 von Eckardstein A, Funke H, Chirazi A, Chen-Haudenschild C, Schulte H, Schonfeld R, Kohler E, Schwarz S, Steinmetz A, Assmann G. Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism. Arterioscler Thromb 1994; 14: 114-1120.
47. 47 McCombs RJ, Maracdis DE, Ellis J, Weinberg RB. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. New Engl J Med 1994; 331: 706-710.
48. 48 Mata P, Ordovas JM, Lopez-Miranda J, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ. ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler Thromb 1994; 14: 884-891.
49. 49 Jansen S, Lopez-Miranda J, Salas J, Ordovas JM, Castro P, Marin C, Ostos MA, Lopez-Segura F, Jiminez-Pereperez J, Blanco A, Perez-Jiminez F. Effect of 347-serine mutation in apoprotein A-IV on plasma LDL cholesterol response to dietary fat. Arterioscler Thromb Vasc Biol 1997; 17: 1532-1538.
50. 50 Visvikis S, Steinmetz J, Boerwinkle E, Gueguen R, Galteau MM, Siest G. Frequency and effects of the apolipoprotein A-IV polymorphism. Clin Genet 1990; 37: 435-441.
51. 51 Rewers M, Kamboh MI, Hoag S, Shetterly SM, Ferrell RE, Hamman RF. ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. Diabetes 1994; 43: 1485-1489.
52. 52 Fukagawa K, Knight DS, Hamilton KA, Tso P. Immunoreactivity for apolipoprotein A-IV in tanycytes and astrocytes of rat brain. Neurosci Lett 1995; 199: 17-20.
53. 53 Aalto-Setälä K, Bisgaier CL, Ho A, Kieft KA, Traber MG, Kayden HJ, Ramakrishnan R, Walsh A, Essenburg AD, Breslow JL. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J Biol Chem 1994; 93: 1776-1786.
54. 54 Greenwood M. The relationship of enzyme activity to feeding behavior in rats: lipoprotein lipase as the metabolic gate-keeper. Int J Obes 1985; 9(Suppl 1): 67-70.
55. 55 Weinberg RB, Patton CS. Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim Biophys Acta 1990; 1044: 255-261.
56. 56 Ghiselli G, Crump WL, Gotto AM, Jr. Binding of apoA-IV phospholipid complexes to plasma membranes of rat liver. Biochem Biophys Res Commun 1996; 139: 122-128.
57. 57 Karathanasis SK. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV gene. Proc Natl Acad Sci USA 1985; 83: 6374-6378.
58. 58 Norman RA, Thompson DB, Foroud T, Bennett PH, Bogardus C, Ravussin E. Genome wide search for genes influenciong percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. Pima Diabetes Gene Group. Am J Hum Genet 1997; 60: 166-173.
59. 59 West DB, Goudey-Lefevre J, York B, Truett GE. Dietary obesity linked to genetic loci on chromosomes 9 and 15 in a polygenic mouse model. J Clin Invest 1994; 94: 1410-1416.